Action of Docosa-Hexaenoic Acid is their interference with MAP kinase signaling in mouse CD4+ T cells
| dc.contributor.author | ATTAKPA, S. EUGÈNE | |
| dc.contributor.author | SEZAN, ALPHONSE | |
| dc.contributor.author | Seri, Bialli | |
| dc.contributor.author | Khan, Naim Akhtar | |
| dc.date.accessioned | 2026-06-02T16:06:57Z | |
| dc.date.available | 2026-06-02T16:06:57Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | assessed their effects on the activation of two mitogen activated protein (MAP) kinases, i.e. extracellularly-regulated kinases 1 and 2 (ERK1/ERK2) in mouse CD4+ T cells. The n-3 polyunsaturated fatty acids (PUFAs) alone failed to induce MAP kinase (MAPK) enzyme activity. To elucidate whether DHA act via protein kinase C (PKC) dependent and independent pathways, we employed their respective activators, i.e. phorbol 12-myristate 13-acetate (PMA) and anti-CD3 antibodies. DHA diminished the PMA- and anti-CD3-induced phosphorylation of ERK1/ERK2 CD4+ T cells. In the present study, PMA acts mainly via protein kinase C (PKC) whereas anti-CD3 antibodies act via PKC-dependent and–independent mechanisms. We observed that DHA inhibited PMA-stimulated PKC enzyme activity. Together these results suggest that DHA modulate ERK1/ERK2 activation upstream of MEK via PKC-dependent and independent pathways and that these actions may be implicated in DHA-induced immunosuppression. Our study shows that DHA inhibits cell cycle progression. | |
| dc.identifier.other | BECDB-3155 | |
| dc.identifier.uri | https://dspace.uac.bj/handle/123456789/3135 | |
| dc.language.iso | fr | |
| dc.relation.ispartof | Journal of Pharmaceutical and Biomedical Sciences | |
| dc.subject | Mouse | |
| dc.subject | CD4+ T cells | |
| dc.subject | DHA | |
| dc.subject | ERK. | |
| dc.title | Action of Docosa-Hexaenoic Acid is their interference with MAP kinase signaling in mouse CD4+ T cells | |
| dc.type | Article |
